BIOTECH-IGG ApS: Financial statements 2012
CVR: 32099807
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BIOTECH-IGG ApS (CVR 32099807) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 360,896 and a net result of DKK -370,762. Equity in the 2012 report amounted to DKK 693,256. The solvency ratio was 60.1%.
- Gross Profit
- DKK 360,896
- Profit/Loss
- DKK -370,762
- Equity
- DKK 693,256
- Total Assets
- DKK 1,153,932
Keep an eye on BIOTECH-IGG ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 24, 2012, Kirstin Ann Kriz is registered as direktion of BIOTECH-IGG ApS.
As of April 24, 2012, Alistair John Hurst has stepped down as direktion of BIOTECH-IGG ApS.
About BIOTECH-IGG ApS
BIOTECH-IGG ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2009. The company has been dissolved on 3 November 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 2 employees (2017). In 2017, the company reported a gross profit of DKK -102,019 and a net result of DKK -556,494 compared with DKK 12,659 the year before. Equity in the 2017 report amounted to DKK 633,705.